General form of registration statement for all companies including face-amount certificate companies

COMMITMENTS AND CONTINGENCIES (Details Textual)

v3.2.0.727
COMMITMENTS AND CONTINGENCIES (Details Textual) - USD ($)
 3 Months Ended 12 Months Ended
Aug. 06, 2013
Mar. 31, 2015
Mar. 31, 2014
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2011
Operating Leased Assets [Line Items]            
Operating Leases, Rent Expense, Net   $ 19,015 $ 5,400 $ 21,600 $ 25,200  
Licensing Agreements [Member]            
Operating Leased Assets [Line Items]            
Milestone Payment $ 765,000         $ 765,000
Maintenance fees for First Five Years           80,000
Annual Maintenance fees after First Five Years           $ 50,000
Royalty percentage 2.00%         2.00%
Minimum Royalty Expense $ 75,000         $ 75,000
Royalty Percentage Payment Terms           The Company is required to pay The Regents royalties ranging from 8% of worldwide sublicense sales of covered products (if the sublicense is entered after commencement of phase II clinical trials to 12% of worldwide sublicense sales (if the sublicense is entered prior to commencement of phase I clinical trials).
Initial; License Fee $ 10,000          
Laboratory Space [Member]            
Operating Leased Assets [Line Items]            
Operating Leases, Rent Expense, Net   $ 5,700